Related Experiment Videos
Evaluation of multiple regimens in leprosy
Abstract:
Assessment of bacteraemia has been made at weekly intervals in 36 lepromatous leprosy patients who were put on different antileprosy drug under four regimens, viz., DDS alone, DDS in combination with rifampicin (DDS + RIF), clofazimine (DDS + CLF) and thiacetazone (DDS + TCT). In general, with the continuation of treatment the bacillary load in the blood decreased considerably while bacteriological index (BI) of the skin remained constant during the study. No significant difference was noted in M. leprae clearance from blood between the groups treated with DDS alone and groups treated in combination with CLF and TCT. However, DDS + RIF treatment was most efficient in clearing acid-fast bacilli (AFB) from blood as compared to those noted with other drug regimens.
Insights
Leprosy patients showed reduced bacillary load with treatment. Dapsone combined with rifampicin (DDS + RIF) was most effective in clearing Mycobacterium leprae from the blood compared to other drug regimens.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Dermatology
Background:
- Leprosy, caused by Mycobacterium leprae, remains a global health concern.
- Bacteraemia is a significant indicator of disease activity and treatment response in leprosy.
Purpose of the Study:
- To evaluate the efficacy of different antileprosy drug regimens in clearing Mycobacterium leprae from the bloodstream.
- To compare the impact of dapsone monotherapy versus combination therapies on bacteraemia in lepromatous leprosy.
Main Methods:
- Weekly assessment of bacteraemia in 36 lepromatous leprosy patients.
- Patients received one of four regimens: dapsone alone (DDS), DDS + rifampicin (RIF), DDS + clofazimine (CLF), or DDS + thiacetazone (TCT).
- Bacteriological index (BI) of skin lesions was monitored concurrently.
Main Results:
- Overall, treatment led to a considerable decrease in bacillary load in the blood.
- Skin bacteriological index remained relatively constant throughout the study period.
- Dapsone + rifampicin (DDS + RIF) demonstrated superior efficacy in clearing acid-fast bacilli (AFB) from blood compared to other regimens.
- No significant difference in M. leprae clearance from blood was observed between DDS alone and DDS + CLF or DDS + TCT groups.
Conclusions:
- Combination therapy with DDS + RIF is highly effective for reducing bacteraemia in lepromatous leprosy.
- Monitoring blood bacillary load is crucial for assessing treatment effectiveness.
- Further research into optimal combination therapies for leprosy is warranted.